Access Business Clinical Trials Compliance 
Cannabis Law Report
JANUARY 14, 2022
THE Member of Parliament sponsoring the Medical Cannabis Access Bill in the House of Commons today has acknowledged it is set to fail due to lack of political support. Cannabis Trials. BusinessCann UK reports that the UK Medical Cannabis Bill has Buckley’s chance.
Cannabis Law Report
AUGUST 7, 2021
The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. MAPS PBC strives to establish a supportive, equitable, and accessible work environment. Strong aptitude for learning critical business software.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
NOVEMBER 19, 2021
It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. MAPS PBC strives to establish a supportive, equitable and accessible work environment. European Regulatory Lead Executive Summary.
Cannabis Law Report
OCTOBER 2, 2021
The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. MAPS PBC strives to establish a supportive, equitable, and accessible work environment. Strong aptitude for learning critical business software.
Cannabis Law Report
SEPTEMBER 8, 2021
Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).
Cannabis Law Report
MAY 31, 2022
The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. 2022 Active FDA Clinical Trials and State-Regulated Systems. Active FDA Regulated Clinical Trials*. On March 5, 2019, the U.S. Schedule I.
MMJ Recs
APRIL 1, 2024
Furthermore, ongoing clinical trials are investigating CBD’s efficacy in treating conditions such as multiple sclerosis, Parkinson’s disease, and substance abuse disorders. CBD Oil for Medical Conditions CBD oil has gained popularity as a versatile and accessible option for managing various medical conditions.
Expert insights. Personalized for you.
52 
Let's personalize your content